These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 21840549)
1. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett's esophagus: a single-center, phase II clinical trial. Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1168-73. PubMed ID: 21840549 [TBL] [Abstract][Full Text] [Related]
2. Barrett's esophagus: prevalence and size of hiatal hernia. Cameron AJ Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527 [TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm. dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750 [TBL] [Abstract][Full Text] [Related]
4. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett's esophagus with early neoplasia. Pouw RE; Wirths K; Eisendrath P; Sondermeijer CM; Ten Kate FJ; Fockens P; Devière J; Neuhaus H; Bergman JJ Clin Gastroenterol Hepatol; 2010 Jan; 8(1):23-9. PubMed ID: 19602454 [TBL] [Abstract][Full Text] [Related]
7. Validation of the Prague C&M classification of Barrett's esophagus in clinical practice. Alvarez Herrero L; Curvers WL; van Vilsteren FG; Wolfsen H; Ragunath K; Wong Kee Song LM; Mallant-Hent RC; van Oijen A; Scholten P; Schoon EJ; Schenk EB; Weusten BL; Bergman JG Endoscopy; 2013 Nov; 45(11):876-82. PubMed ID: 24165812 [TBL] [Abstract][Full Text] [Related]
8. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Hernandez JC; Reicher S; Chung D; Pham BV; Tsai F; Disibio G; French S; Eysselein VE Endoscopy; 2008 May; 40(5):388-92. PubMed ID: 18459075 [TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus. Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1529-34. PubMed ID: 23219501 [TBL] [Abstract][Full Text] [Related]
10. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546 [TBL] [Abstract][Full Text] [Related]
11. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD]. Endzinas Z; Mickevicius A; Kiudelis M Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039 [TBL] [Abstract][Full Text] [Related]
12. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074 [TBL] [Abstract][Full Text] [Related]
13. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
14. A predictive model for length of Barrett's esophagus with hiatal hernia length and duration of esophageal acid exposure. Wakelin DE; Al-Mutawa T; Wendel C; Green C; Garewal HS; Fass R Gastrointest Endosc; 2003 Sep; 58(3):350-5. PubMed ID: 14528207 [TBL] [Abstract][Full Text] [Related]
15. Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation. Krishnan K; Pandolfino JE; Kahrilas PJ; Keefer L; Boris L; Komanduri S Gastroenterology; 2012 Sep; 143(3):576-581. PubMed ID: 22609385 [TBL] [Abstract][Full Text] [Related]
16. Length of Barrett's segment predicts failure of eradication in radiofrequency ablation for Barrett's esophagus: a retrospective cohort study. Luckett T; Allamneni C; Cowley K; Eick J; Gullick A; Peter S BMC Gastroenterol; 2018 May; 18(1):67. PubMed ID: 29783927 [TBL] [Abstract][Full Text] [Related]
17. Balloon-based electrode for the ablation of non-dysplastic Barrett's esophagus: ablation of intestinal metaplasia (AIM II Trial). Avilés A; Reymunde A; Santiago N Bol Asoc Med P R; 2006; 98(4):270-5. PubMed ID: 19610568 [TBL] [Abstract][Full Text] [Related]
18. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Weston AP; Badr AS; Hassanein RS Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296 [TBL] [Abstract][Full Text] [Related]